Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 11 of 12
Use of Laryngeal Mask Airway in Pediatric Adenotonsillectomy
NCT01141660
Barriers to Effective Weight Loss in Overweight Adolescents
NCT00562263
An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care
NCT00589173
Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
NCT00498498
Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV
NCT00575757
Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women
NCT00201448
Prevention of Self-care Deterioration in Early Adolescents With Diabetes
NCT00890331
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
NCT00580970
Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation
NCT00571597
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
NCT00581113
Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
NCT00436865
Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents
NCT00369967
Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
NCT00409084
Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation
NCT00615719
Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain
NCT00373633
Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children
NCT00308906
A Comprehensive Practice-Friendly Model for Promoting Healthy Behaviors
NCT00292968
Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC
NCT00692380
Tolerability and Efficacy of Depakote-extended Release in the Elderly
NCT00318929
New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy
NCT00283348
Insulin and Polycystic Ovary Syndrome
NCT00683774
Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
NCT00252642
Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
NCT00682890
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
NCT00390559
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
NCT00107484
Development of a Breath Test for Monitoring Patients With Liver Disease
NCT00244569
A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP
NCT00248300
Oral Contraceptives in the Metabolic Syndrome
NCT00205504
Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees
NCT00249379
Pilot Study of 18F Fluoropaclitaxel (FPAC)
NCT00572598
Botox for Non-surgical Lateral Release in Patellofemoral Pain
NCT00496964
Pharmacological Intervention in Depression After Traumatic Brain Injury
NCT00205491
A Prospective Study of Natural History of Pancreatitis
NCT00685087
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
NCT00580320
Study of Effects of Sutures on Results of Palate Surgery for Obstructive Sleep Apnea
NCT00205543
HIV-HCV Coinfection: Impact of Immune Dysfunction
NCT00575315
Histamine Pharmacogenetics in Children With Atopic Dermatitis
NCT00277433
Barriers to Treatment in Obese Adolescents
NCT00167830
Checking Smoking Status as a Routine Vital Sign: A Cluster-Randomized Trial of Its Effect on Cessation Counseling
NCT00245323
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
NCT00064285
Transplant Patient Registry of Liver, Kidney and/or Pancreas
NCT00238693
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer
NCT00243321
Evaluation of an Intervention Model for Family Crisis and Support
NCT00205530
Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea
NCT00310323
Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation
NCT00205569
Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection
NCT00248339
Strategies to Prevent Pneumonia (SToP Pneumonia)
NCT00234598
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00017342
Treatment of Alcohol Withdrawal in Hospital Patients
NCT00249366
Oral Administration of DCI to Women With PCOS
NCT00497653
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.